News | September 12, 2011

September 12, 2011 — Cardiovascular market research firm Zacks Equity Research released a new report discussing high...

News | September 12, 2011

September 12, 2011 — TeraRecon Inc. invited interventional specialists to “Intervene with iNtuition,” the company’s...

News | September 12, 2011

September 12, 2011 — Life Recovery Systems (LRS) announced it has been awarded a new three-year agreement by Premier...

News | September 09, 2011

September 9, 2011 — GE Healthcare announced it has received commitments from more than 100 customers globally for...

News | September 09, 2011

September 9, 2011 — Angioslide Ltd. announced the first procedures with its new 5 x 300 mm Proteus device for...

News | September 08, 2011

September 8, 2011 – Concentric Medical announced completion of enrollment of the TREVO Study. The TREVO Study (...

News | September 08, 2011

September 8, 2011 – Abbott announced the initiation of ABSORB BTK, an international clinical trial evaluating the...

News | September 08, 2011

September 8, 2011 – SynCardia Systems, manufacturer of the SynCardia temporary Total Artificial Heart, announced...

News | September 08, 2011

September 8, 2011 – Intra-aortic balloon pump (IABP) counterpulsation prior to percutaneous coronary intervention (...

News | September 08, 2011

September 8, 2011 – A randomized multicenter, open-label study evaluating the efficacy and safety of prolonged...

Feature | September 08, 2011

September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer...

News | September 06, 2011

September 6, 2011 — Philips has announced the availability of Xcelera R3.2, the latest release of its multi-modality...

News | September 06, 2011

September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for...

News | September 06, 2011

September 6, 2011 — Stryker Corp. has signed a definitive agreement to acquire Concentric Medical for $135 million...

News | September 06, 2011

September 6, 2011 — Mesoblast Ltd. announced it received clearance from the European Medicines Agency (EMA) to begin...

Overlay Init